0001579428-15-000002.txt : 20150519 0001579428-15-000002.hdr.sgml : 20150519 20150519163357 ACCESSION NUMBER: 0001579428-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150519 DATE AS OF CHANGE: 20150519 EFFECTIVENESS DATE: 20150519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-240209 FILM NUMBER: 15876899 BUSINESS ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA, SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 BUSINESS PHONE: 212-203-5072 MAIL ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA, SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 D 1 primary_doc.xml X0707 D LIVE 0001579428 Axsome Therapeutics, Inc. 45 ROCKEFELLER PLAZA, 20th Floor NEW YORK NY NEW YORK 10111 212-203-5072 DELAWARE None None Corporation true 2012 Herriot Tabuteau 45 Rockefeller Plaza, 20th Floor New York NY NEW YORK 10111 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2015-05-06 false true true true false 25000 7500000 2460000 5040000 false 14 0 0 0 false Axsome Therapeutics, Inc. Herriot Tabuteau Herriot Tabuteau Chief Executive Officer 2015-05-19